Related Experiment Video
Updated: Mar 16, 2026

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
Bilateral Central Retinal Vein Occlusion as Presenting Feature of Chronic Myeloid Leukemia
Subina Narang1, Panchmi Gupta1, Anuj Sharma1
1Department of Ophthalmology, Government Medical College and Hospital, Chandigarh, India.
Insights
Bilateral central retinal vein occlusion (CRVO) can signal underlying leukemia. Ophthalmologists play a crucial role in diagnosing this rare, life-threatening hematological condition through initial patient presentation.
Area of Science:
- Ophthalmology
- Hematology
- Vascular Medicine
Background:
- Central retinal vein occlusion (CRVO) is a common retinal vascular disease, typically unilateral.
- CRVO management focuses on preventing blinding complications, as specific therapies are limited.
- Bilateral CRVO often indicates an underlying systemic illness, such as hyperviscosity syndrome.
Observation:
- A patient presented with a sudden, bilateral decrease in visual acuity.
- Ophthalmic evaluation diagnosed the condition as bilateral central retinal vein occlusion.
- Subsequent systemic investigation revealed an undiagnosed chronic myeloid leukemia.
Findings:
- The case demonstrates a rare instance of chronic myeloid leukemia presenting initially to an ophthalmologist.
- Bilateral CRVO served as the presenting sign for a significant hematological malignancy.
- Early ophthalmic detection facilitated the diagnosis of a potentially life-threatening systemic disease.
Implications:
- Highlights the critical role of ophthalmologists in identifying systemic diseases beyond ocular manifestations.
- Emphasizes the need for comprehensive systemic workup in cases of bilateral CRVO.
- Underscores the importance of recognizing rare presentations of hematological malignancies in ophthalmic practice.
Abstract:
Central retinal vein occlusion (CRVO) is a common pathology of the retinal vasculature. Patients with CRVO usually present with a drop in visual acuity. The condition bears no specific therapy; treatment is aimed at the management of potentially blinding complications, of which there are many. With majority of cases being unilateral, bilateral CRVO is usually associated with an underlying systemic illness such as a hyperviscosity syndrome. Here, we present a case of a patient, who presented with a bilateral drop in vision diagnosed as bilateral CRVO on ophthalmic evaluation. Systemic workup revealed the presence of an underlying undiagnosed chronic myeloid leukemia. An initial presentation to the ophthalmologist is a rare occurrence in leukemic patients. This case report highlights the role of the ophthalmologist in diagnosing a potentially life-threatening hematological illness.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

